A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Genetically Modified Primary Cells for Allogeneic Cell Therapy
What It Covers This patent application describes engineered primary cells with multiple genetic modifications designed for allogeneic (off-the-shelf) cell therapy — meaning they can be administered into genetically unmatched recipients without triggering strong immune rejection.…
-
Recombinant Antibodies and Uses Thereof
Publication No.: WO 2025 058631 A1Publication Date: March 20, 2025Filing (Priority) Date: September 17, 2023 (PCT/US2023/032971)Jurisdiction: International (PCT publication; can enter national phases)Tech Field: Recombinant antibody therapeutics What This Patent Application Covers This patent application describes recombinant antibodies and their uses, including…
-
Internal cap-initiated translation for efficient protein production from circular mRNA
Published in Nature Biotechnology (February 19, 2025) — this study introduces a novel internal cap-initiated mechanism that significantly enhances the efficiency of protein production from circular mRNA therapeutics. What it covers Traditionally, circular mRNAs —…
BioTech IP Review 